Using chemical proteomics, we analyzed the target spectrum of 243 clinically evaluated kinase drugs. The data revealed previously unknown targets for established drugs, offered a perspective on the “druggable” kinome, highlighted...
Most molecular cancer therapies act on protein targets but data on the proteome status of patients and cellular models for proteome‐guided pre‐clinical drug sensitivity studies are only beginning to emerge. Here, we profiled the...
ProteomicsDB is a protein-centric in-memory database for the exploration of large collections of quantitative mass spectrometry-based proteomics data and is highlighted in the database issue of Nucleic Acids Research.
A Triazene linker helps identify azidation sites of labelled proteins via click and cleave strategy. A method for identifying probe modification of proteins via tandem mass spectrometry was developed.
Here, we describe PROCAL (ProteomeTools Calibration Standard), a set of 40 synthetic peptides standards for retention time indexing, column performance monitoring and collision energy calibration.
02.08.2017 Trimodal mixed mode chromatography enables efficient offline 2D peptide fractionation for proteome analysis
Here, we report an alternative first-dimension separation technique using a commercial trimodal phase incorporating polar embedded reversed phase, weak anion exchange and strong cation exchange material.
10.04.2017 Three awards at Proteomic Forum 2017
We are pleased to announce that members of the chair have been awarded at the Annual meeting of the German Society for Proteome Research (DGMS) in Potsdam.